Cfdp1 Is Essential for Cardiac Development and Function
Cells · 2023
DOI: 10.3390/cells12151994 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Panagiota Giardoglou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Zebrafish Disease Model Laboratory, Center for Clinical, Experimental Surgery & Translational Research, Biomedical Research Foundation, Academy of At…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Nuclear Proteins, Zebrafish. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, British Heart Foundation, State Scholarships Foundation.
Abstract (Originalsprache)
Cardiovascular diseases (CVDs) are the prevalent cause of mortality worldwide. A combination of environmental and genetic effectors modulates the risk of developing them. Thus, it is vital to identify candidate genes and elucidate their role in the manifestation of the disease. Large-scale human studies have revealed the implication of Craniofacial Development Protein 1 (CFDP1) in Coronary Artery Disease (CAD). CFDP1 belongs to the evolutionary conserved Bucentaur (BCNT) family, and to date, its function and mechanism of action in Cardiovascular Development are still unclear. We utilized zebrafish to investigate the role of cfdp1 in the developing heart due to the high genomic homology, similarity in heart physiology, and ease of experimental manipulations. We showed that cfdp1 was expressed during development, and we tested two morpholinos and generated a cfdp1 mutant line. The cfdp1−/− embryos developed arrhythmic hearts and exhibited defective cardiac performance, which led to a lethal phenotype. Findings from both knockdown and knockout experiments showed that abrogation of cfdp1 leads to downregulation of Wnt signaling in embryonic hearts during valve development but without affecting Notch activation in this process. The cfdp1 zebrafish mutant line provides a valuable tool for unveiling the novel mechanism of regulating cardiac physiology and function. cfdp1 is essential for cardiac development, a previously unreported phenotype most likely due to early lethality in mice. The detected phenotype of bradycardia and arrhythmias is an observation with potential clinical relevance for humans carrying heterozygous CFDP1 mutations and their risk of developing CAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zebrafish Disease Model Laboratory, Center for Clinical, Experimental Surgery & Translational Research, Biomedical Research Foundation, Academy of Athens, 11527 Athens, Greece.
- Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University of Athens, 17676 Athens, Greece.
- Clinical Pharmacology, William Harvey Research Institute, Barts and The London Medical School, Queen Mary University of London, London E1 4NS, UK.
- Laboratory of Biological Chemistry, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece.
ORCID-Profile: George Dedoussis, Dimitris Beis
Förderung
- Wellcome Trust
- British Heart Foundation
- State Scholarships Foundation
- RESEARCH – CREATE – INNOVATE
Zitieren
APA
Giardoglou, P., Deloukas, P., Dedoussis, G., & Beis, D. (2023). Cfdp1 Is Essential for Cardiac Development and Function. Cells. https://doi.org/10.3390/cells12151994
Vancouver
Giardoglou P, Deloukas P, Dedoussis G, Beis D. Cfdp1 Is Essential for Cardiac Development and Function. Cells. 2023. doi:10.3390/cells12151994
BibTeX
@article{Giardoglou2023,
author = {Giardoglou, Panagiota and Deloukas, Panos and Dedoussis, George and Beis, Dimitris},
title = {Cfdp1 Is Essential for Cardiac Development and Function},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12151994}
}
EUVIMED